EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sex Differences in Onset and Progression of Cerebral Amyloid Angiopathy

Emma A Koemans iD, Juan Pablo Castello, Ingeborg Rasing iD, Jessica R Abramson iD, Sabine Voigt iD, Valentina Perosa iD, Thijs W van Harten iD, Erik W van Zwet, Gisela M Terwindt iD, M Edip Gurol iD, Jonathan Rosand iD, Steven M Greenberg iD und 4 weitere

Stroke · 2023-02 · 54 (2) · 306-314

DOI: 10.1161/strokeaha.122.040823 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke, 2023-02. Verfasst von Emma A Koemans und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Leiden University Medical Center, the Netherlands (E.A.K., I.R., S.V., G.M.T., M.J.H.W.). Hauptthemen laut MEDLINE: Cerebral Amyloid Angiopathy, Cerebral Amyloid Angiopathy, Familial. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cerebral Amyloid Angiopathy (CAA) disease course is highly variable even in hereditary forms. Sex may be a possible modifying factor. We investigated biological sex differences in clinical disease course and magnetic resonance imaging-markers in sporadic (sCAA) and Dutch-type hereditary CAA (D-CAA).

Methods

Patients with D-CAA and sCAA were included from hospital and research databases of the Leiden University Medical Center (2012–2020) and Massachusetts General Hospital (1994–2012). Key outcomes were: sex differences in symptomatic intracerebral hemorrhage (sICH) onset, recurrence and survival (analyzed using Kaplan Meier survival and regression analyses), and sex differences in magnetic resonance imaging-markers in D-CAA (explored using scatterplots), and in sCAA (investigated using regression analysis).

Results

We included 136 patients with D-CAA (mean age 57 years, 56% women, 64% with previous sICH) and 370 patients with sCAA (mean age 76 years, 51% women, all with previous sICH). Men and women with D-CAA did not differ for sICH onset (median age 54 in men and 56 in women [ P =0.13]). Men with D-CAA had a slightly higher number of sICH compared with women (median 2 versus 1; adjusted RR, 1.5 [95% CI, 1.1–1.9]) and a shorter interval between the first and second sICH (median 1.8 years for men and 3.1 years for women, P =0.02). Men with sCAA had their first sICH at an earlier age (median 75 versus 78 years, respectively, P =0.003) and more lobar microbleeds (median 1 versus 0, P =0.022) compared with women with sCAA. No substantial differences were found in the other magnetic resonance imaging markers. Survival after first sICH was comparable between sexes for D-CAA ( P =0.12) and sCAA ( P =0.23).

Conclusions

Men with CAA seem to have an earlier onset (sCAA) and more hemorrhagic disease course (sCAA and D-CAA) compared with women. Future studies are necessary to confirm these findings and determine the underlying role of sex-related factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral Amyloid AngiopathyCerebral Amyloid Angiopathy, FamilialHumansMaleFemaleMiddle AgedAgedSex CharacteristicsCerebral HemorrhageMagnetic Resonance Imaging

Autor:innen und Institutionen

  • Department of Neurology, Leiden University Medical Center, the Netherlands (E.A.K., I.R., S.V., G.M.T., M.J.H.W.).
  • Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Harvard Medical School, Boston (J.P.C., J.R.A., J.R., A.B.).
  • Department of Neurology, J Philip Kistler Stroke Research Center, Massachusetts General Hospital, Harvard Medical School, Boston (J.P.C., J.R.A., V.P., M.E.G., J.R., S.M.G., A.B., A.V.).
  • Department of Neurology, University of Miami Miller School of Medicine, FL (J.P.C.).
  • Department of Radiology, Leiden University Medical Center, the Netherlands (S.V., T.W.v.H., M.A.A.v.W.).
  • Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany (V.P.).

ORCID-Profile: Emma A Koemans, Ingeborg Rasing, Jessica R Abramson, Sabine Voigt, Valentina Perosa, Thijs W van Harten, Gisela M Terwindt, M Edip Gurol, Jonathan Rosand, Steven M Greenberg, Marianne A A van Walderveen, Alessandro Biffi, Anand Viswanathan, Marieke J H Wermer

Förderung

  • NINDS NIH HHS

Zitieren

APA

Koemans, E. A., Castello, J. P., Rasing, I., Abramson, J. R., Voigt, S., Perosa, V., van Harten, T. W., van Zwet, E. W., Terwindt, G. M., Gurol, M. E., Rosand, J., Greenberg, S. M., van Walderveen, M. A. A., Biffi, A., Viswanathan, A., & Wermer, M. J. H. (2023). Sex Differences in Onset and Progression of Cerebral Amyloid Angiopathy. Stroke, 54(2), 306-314. https://doi.org/10.1161/strokeaha.122.040823

Vancouver

Koemans EA, Castello JP, Rasing I, Abramson JR, Voigt S, Perosa V, et al. Sex Differences in Onset and Progression of Cerebral Amyloid Angiopathy. Stroke. 2023;54(2):306-314. doi:10.1161/strokeaha.122.040823

BibTeX
@article{Koemans2023,
  author = {Koemans, Emma A and Castello, Juan Pablo and Rasing, Ingeborg and Abramson, Jessica R and Voigt, Sabine and Perosa, Valentina and van Harten, Thijs W and van Zwet, Erik W and Terwindt, Gisela M and Gurol, M Edip and Rosand, Jonathan and Greenberg, Steven M and van Walderveen, Marianne A A and Biffi, Alessandro and Viswanathan, Anand and Wermer, Marieke J H},
  title = {Sex Differences in Onset and Progression of Cerebral Amyloid Angiopathy},
  journal = {Stroke},
  year = {2023},
  volume = {54},
  number = {2},
  pages = {306--314},
  doi = {10.1161/strokeaha.122.040823}
}
Kostenlos starten →